Literature DB >> 7972096

Attenuation of bovine leukemia virus by deletion of R3 and G4 open reading frames.

L Willems1, P Kerkhofs, F Dequiedt, D Portetelle, M Mammerickx, A Burny, R Kettmann.   

Abstract

Complex oncoviruses contain, in addition to the classical retroviral genes (gag, pol, and env), a region (X) located between the envelope sequences and the 3' long terminal repeat. The X region contains two genes, tax and rex, whose protein products are involved in transcriptional and posttranscriptional regulation of viral expression. In addition to these activators, the bovine leukemia virus (BLV) and the human T-cell leukemia virus (HTLV) contain alternative open reading frames (R3 and G4 for BLV; p30, p13, and p12 for HTLV). As a virus/animal model for HTLV-induced leukemogenesis, BLV provirus can be injected intradermally into sheep, where it induced B-lymphocyte transformation. Deletion of the R3 and G4 sequences from an infectious and tumorigenic BLV provirus greatly impaired the in vivo propagation of the viruses as demonstrated by DNA polymerase chain reaction, RNA blots, structural-protein ELISA, and immunofluorescence analysis. Our results show that the alternative open reading frames are required for maintaining high virus loads during the course of persistent infection in vivo. Thus, R3 and G4 are candidates for antiviral drug development. Furthermore, viruses with a deletion in these sequences should be tested as live attenuated vaccines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7972096      PMCID: PMC45265          DOI: 10.1073/pnas.91.24.11532

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.

Authors:  D Portetelle; K Limbach; A Burny; M Mammerickx; P Desmettre; M Riviere; J Zavada; E Paoletti
Journal:  Vaccine       Date:  1991-03       Impact factor: 3.641

2.  Use of two monoclonal antibodies in an ELISA test for the detection of antibodies to bovine leukaemia virus envelope protein gp51.

Authors:  D Portetelle; M Mammerickx; A Burny
Journal:  J Virol Methods       Date:  1989-02       Impact factor: 2.014

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses.

Authors:  N Sagata; T Yasunaga; J Tsuzuku-Kawamura; K Ohishi; Y Ogawa; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

5.  The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase.

Authors:  G Franchini; J C Mulloy; I J Koralnik; A Lo Monico; J J Sparkowski; T Andresson; D J Goldstein; R Schlegel
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Bovine leukemia virus, an animal model for the study of intrastrain variability.

Authors:  L Willems; E Thienpont; P Kerkhofs; A Burny; M Mammerickx; R Kettmann
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

7.  In vivo infection of sheep by bovine leukemia virus mutants.

Authors:  L Willems; R Kettmann; F Dequiedt; D Portetelle; V Vonèche; I Cornil; P Kerkhofs; A Burny; M Mammerickx
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus.

Authors:  S Alexandersen; S Carpenter; J Christensen; T Storgaard; B Viuff; Y Wannemuehler; J Belousov; J A Roth
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

  8 in total
  35 in total

1.  Assessment of bovine leukemia virus transcripts in vivo.

Authors:  J Rovnak; J W Casey
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 2.  The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

Authors:  D M D'Agostino; M Silic-Benussi; H Hiraragi; M D Lairmore; V Ciminale
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

3.  Prostaglandin E2-Induced Immune Exhaustion and Enhancement of Antiviral Effects by Anti-PD-L1 Antibody Combined with COX-2 Inhibitor in Bovine Leukemia Virus Infection.

Authors:  Yamato Sajiki; Satoru Konnai; Tomohiro Okagawa; Asami Nishimori; Naoya Maekawa; Shinya Goto; Kei Watari; Erina Minato; Atsushi Kobayashi; Junko Kohara; Shinji Yamada; Mika K Kaneko; Yukinari Kato; Hirofumi Takahashi; Nobuhiro Terasaki; Akira Takeda; Keiichi Yamamoto; Mikihiro Toda; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  J Immunol       Date:  2019-07-31       Impact factor: 5.422

4.  Human T-cell leukemia virus type 1 pX-I and pX-II open reading frames are dispensable for the immortalization of primary lymphocytes.

Authors:  M D Robek; F H Wong; L Ratner
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus.

Authors:  A Van den Broeke; Y Cleuter; T Beskorwayne; P Kerkhofs; M Szynal; C Bagnis; A Burny; P Griebel
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 6.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

7.  Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Authors:  Hajime Hiraragi; Seung-Jae Kim; Andrew J Phipps; Micol Silic-Benussi; Vincenzo Ciminale; Lee Ratner; Patrick L Green; Michael D Lairmore
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1.

Authors:  Micol Silic-Benussi; Ilaria Cavallari; Tatiana Zorzan; Elisabetta Rossi; Hajime Hiraragi; Antonio Rosato; Kyoji Horie; Daniela Saggioro; Michael D Lairmore; Luc Willems; Luigi Chieco-Bianchi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-20       Impact factor: 11.205

Review 9.  Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression.

Authors:  Michael Bindhu; Amrithraj Nair; Michael D Lairmore
Journal:  Front Biosci       Date:  2004-09-01

10.  In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene.

Authors:  A Van Den Broeke; C Bagnis; M Ciesiolka; Y Cleuter; H Gelderblom; P Kerkhofs; P Griebel; P Mannoni; A Burny
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.